| Atlantic HPC Group Inc Acquires Valley Oasis Development LLC, Adding 29 MW of Contracted Power to Platform |
Globe Newswire |
09/30 |
07:30 |
| Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer |
Globe Newswire |
09/30 |
07:30 |
| Oregon Department of Transportation Selects Rekor Command® to Deliver Safety Alerts Directly to Drivers Statewide |
Globe Newswire |
09/30 |
07:30 |
| Link Publishers Heads to brightonSEO 2026 to Discuss the Future of Search Visibility |
Globe Newswire |
09/30 |
07:02 |
| Ocugen to Participate in Upcoming Scientific Conferences |
Globe Newswire |
09/30 |
07:02 |
| Sono-Tek Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer |
Globe Newswire |
09/30 |
07:00 |
| Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO |
Globe Newswire |
09/30 |
07:00 |
| Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation |
Globe Newswire |
09/30 |
07:00 |
| Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026 |
Globe Newswire |
09/30 |
07:00 |
| ONAR Completes Largest Acquisition in Company History: Advertise Purple Adds $17.1 Million of Revenue and $4.4 Million of Net Income, Bringing Combined Pro Forma Revenue to Approximately $23.5 Million |
Globe Newswire |
09/30 |
07:00 |
| Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy |
Globe Newswire |
09/30 |
07:00 |
| Chilco River Holdings Advances Commercialization Across Premium Spirits Portfolio |
Globe Newswire |
09/30 |
07:00 |
| Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations |
Globe Newswire |
09/30 |
07:00 |
| Beamr Expects Fiscal Year 2026 Revenues to Increase by $1.5 Million Year Over Year |
Globe Newswire |
09/30 |
07:00 |
| Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA) |
Globe Newswire |
09/30 |
07:00 |
| EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application |
Globe Newswire |
09/30 |
07:00 |
| Enigmatig Limited Issues Statement on Recent Share Trading Activity |
Globe Newswire |
09/30 |
07:00 |
| FactSet Reports Results for Fourth Quarter and Fiscal 2026 |
Globe Newswire |
09/30 |
07:00 |
| YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs |
Globe Newswire |
09/30 |
06:55 |
| ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting |
Globe Newswire |
09/30 |
06:55 |
| Nexera Technologies: Subsidiary Fort Technology Targets the Growing Data Center Backup-Power Market Through Acquisition of Majority Stake in Logia USA |
Globe Newswire |
09/30 |
06:55 |
| Alamos Gold Provides Notice of Third Quarter 2026 Results and Conference Call |
Globe Newswire |
09/30 |
06:55 |
| MAPFRE Brazil Increases Customer Retention from 1% to 40% and Protects Revenue within 60 Days of Implementing SuccessKPI AI-Powered Quality Management |
Globe Newswire |
09/30 |
06:50 |
| ASCAR Reports EUR 1 Million+ Turnover in 2026 as Company Outlines 2027 Growth Outlook |
Globe Newswire |
09/30 |
06:45 |
| Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum |
Globe Newswire |
09/30 |
06:45 |
